Results 251 to 260 of about 108,435 (311)

Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation. [PDF]

Hematol Transfus Cell Ther
Shahzad M, Amin MK, Nelson M, Vyas A, Al-Ramahi JS, Ahmed N, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Singh AK, Abhyankar SH, McGuirk JP, Mushtaq MU.   +13 more
europepmc   +1 more source

When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia? [PDF]

Br J Haematol
Dubois S, Layese R, Limal N, Languille L, Kini-Matondo W, Mahevas M, Michel M, Audureau E, Godeau B.   +8 more
europepmc   +1 more source

A Case of Palmoplantar Vesiculobullous Lesions

JEADV Clinical Practice, EarlyView.
Ali Abid, Kelvin Truong, Jing Jing Li, Artiene Tatian   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapeutic intravenous immunoglobulins

Molecular Immunology, 2005
Intravenous immunoglobulins (IVIg) are concentrated formulations of human IgG prepared by industrial fractionation of large pools of individual plasma donations. IVIg were developed 20 years ago for the prophylaxis support of immunodeficient patients.
Réal, Lemieux, Renée, Bazin, Sonia, Néron   +2 more
openaire   +2 more sources

Intravenous immunoglobulin

Clinical Immunology and Immunopathology, 1986
The development of immunoglobulin preparations suitable for intravenous use that are safe, acceptable, and efficacious represents a major advance in the treatment of immunodeficient patients. Experience in the United States and elsewhere in the world indicates that the benefits of use in patients with well-documented humoral immunodeficiency far ...
openaire   +2 more sources

Safety of Intravenous Immunoglobulin

Archives of Neurology, 1993
The current position of intravenous immunoglobulin (IVIG) in neurology is similar to that of plasmapheresis 10 years ago. Therapeutic claims have been made for an increasing number of neurologic disorders, based on small, uncontrolled studies. With the recent publication of a controlled trial of IVIG treatment in Guillain-Barre syndrome, 1 and trials ...
C A, Thornton, M, Ballow
openaire   +2 more sources

Human intravenous immunoglobulin therapy

Seminars in Veterinary Medicine and Surgery: Small Animal, 1997
Human intravenous immunoglobulin (hIVIG) is a preparation of normal polyspecific IgG obtained from the plasma of healthy blood donors. Although purified immunoglobulins were initially developed for treatment of primary immunodeficiency syndromes, they have since been documented to be effective in the treatment of some immune-mediated diseases such as ...
J. Catharine, R. Scott-Moncrieff, William J. Reagan   +2 more
openaire   +2 more sources

Intravenous Immunoglobulin and Atherosclerosis

Clinical Reviews in Allergy & Immunology, 2005
Several inflammatory and immunological factors have been established as important contributors to atherogenesis. Among these, oxidized low-density lipoprotein (oxLDL) play a central role in the initiation and progression of atherosclerotic lesions. In atherosclerotic lesions, oxLDL was also found to co-localize with beta2-glycoprotein I (beta2-GPI ...
Eiji, Matsuura, Kazuko, Kobayashi, Katsumi, Inoue, Yehuda, Shoenfeld   +3 more
openaire   +2 more sources

Intravenous Immunoglobulin and Fibrosis

Clinical Reviews in Allergy & Immunology, 2005
Fibrosis is a pathological process that includes scar formation and overproduction of extracellular matrix by the connective tissue as a response to tissue damage. Pathologies include pathological scarring as colloid and hypertrophic scars in the skin, cirrhosis of liver and gallbladder, pulmonary and bone-marrow fibrosis, and scleroderma.
Vered, Molina, Miri, Blank, Yehuda, Shoenfeld   +2 more
openaire   +2 more sources